Ikarian Capital’s Candel Therapeutics CADL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,400
Closed -$12.2K 129
2024
Q4
$12.2K Buy
+1,400
New +$12.2K ﹤0.01% 118